SynthesisJournal of nephrology2024

Safety and efficacy of sotagliflozin in patients with type II diabetes mellitus and chronic kidney disease: a meta-analysis of randomized controlled trials.

Rafael Dos Santos Borges et al.PubMed ↗Publisher ↗

No numbers read from the abstract.